Ken Fisher
ENTA icon

Ken Fisher’s Enanta Pharmaceuticals ENTA Stock Holding History

Ken Fisher’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,601
Closed -$291K – 946
2021
Q2 		$291K Buy
6,601
+258
+4% +$12.6K ﹤0.01% 810
2021
Q1 		$313K Hold
6,343
– – ﹤0.01% 778
2020
Q4 		$267K Sell
6,343
-100
-2% -$4.4K ﹤0.01% 817
2020
Q3 		$295K Sell
6,443
-2,686
-29% -$130K ﹤0.01% 743
2020
Q2 		$458K Sell
9,129
-2,992
-25% -$155K ﹤0.01% 670
2020
Q1 		$623K Buy
12,121
+29
+0.2% +$1.55K ﹤0.01% 596
2019
Q4 		$747K Hold
12,092
– – ﹤0.01% 620
2019
Q3 		$726K Hold
12,092
– – ﹤0.01% 639
2019
Q2 		$1.02M Sell
12,092
-197
-2% -$17.7K ﹤0.01% 602
2019
Q1 		$1.17M Buy
12,289
+75
+0.6% +$6.73K ﹤0.01% 576
2018
Q4 		$865K Hold
12,214
– – ﹤0.01% 605
2018
Q3 		$1.04M Sell
12,214
-2,469
-17% -$247K ﹤0.01% 579
2018
Q2 		$1.7M Sell
14,683
-5,014
-25% -$500K ﹤0.01% 543
2018
Q1 		$1.59M Buy
+19,697
New +$1.52M ﹤0.01% 536

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ken Fisher's ENTA Position: Q3 2021 in Review

Ken Fisher sold out of Enanta Pharmaceuticals (ENTA) in Q3 2021, closing a stake of 6,601 shares — an estimated $291K sold.

Ken Fisher first reported a position in ENTA in Q1 2018 and held it in 14 quarters. The position peaked at $1.7M in Q2 2018. 148 funds tracked by Wall St. Rank hold ENTA as of Q3 2021.

  • Ken Fisher reported no remaining Enanta Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Ken Fisher sold 6,601 Enanta Pharmaceuticals shares in Q3 2021, an estimated $291K.
  • Ken Fisher first reported a position in Enanta Pharmaceuticals in Q1 2018 and held it in 14 quarters.
  • Ken Fisher's Enanta Pharmaceuticals position peaked at $1.7M in Q2 2018.
  • 148 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2021.

Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.